Peer-reviewedCC BYRSC advances
Radiopharmaceuticals and theranostics: reshaping cancer diagnosis and therapy with targeted radionuclides
- 1Department of Chemistry, COMSATS University Islamabad
- 2Department of Math and Natural Sciences, Gulf University for Science and Technology
Related
- Nanotechnology integration in oncology for advanced nanoparticle based strategies in targeted cancer diagnosis and treatment
- Artificial Intelligence-Enabled Nanomedicine in Precision Oncology: Diagnosis, Targeted Therapy, and Clinical Translation.
- Radionuclidic Impurity Pathways in Cyclotron Production: Insights from 18F and Emerging Theranostic Radionuclides
- A Quantum Mechanism-Centered Review of Carbon Dot-Based Theranostics
- A NIR-II AIEgen with superior fluorescence and photothermal performance for precision theranostics
BibTeX
@article{zulfiqar2026radiopharmaceuticals,
title = {{Radiopharmaceuticals and theranostics: reshaping cancer diagnosis and therapy with targeted radionuclides}},
author = {Humaira Zulfiqar and Muhammad Waqas and Ijaz Ali},
journal = {RSC advances},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701108},
note = {CC BY},
}
RIS
TY - JOUR
TI - Radiopharmaceuticals and theranostics: reshaping cancer diagnosis and therapy with targeted radionuclides
AU - Humaira Zulfiqar
AU - Muhammad Waqas
AU - Ijaz Ali
PY - 2026
DA - 2026/10/27
JO - RSC advances
UR - https://europepmc.org/article/PMC/PMC13701108
SN - 2046-2069
ER -